Gufodotto would like you to read these:

Tuesday, December 05, 2006


It looks like Pfizer has tripped over a CV safety problem with their new (wannabe) blockbuster drug.

Torcetrapib, a compound suppose to reduce (bad) cholesterol production, turned out to cause more heart attacks than it would prevent, possibly due to pressure raising.

This goes a long way to show the importance of my last six months of work. Good feeling. Although I feel bad for Pfizer... Well, not exactly bad, but you know... May be they'll want to hire me, though?

No comments: